BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 21821537)

  • 1. Commentary on selected aspects of cardioprotection.
    Jennings RB
    J Cardiovasc Pharmacol Ther; 2011; 16(3-4):340-8. PubMed ID: 21821537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Reperfusion and postconditioning in acute ST segment elevation myocardial infarction. A new paradigm for the treatment of acute myocardial infarction. From bench to bedside?].
    Lupi Herrera E; Gaspar J; González Pacheco H; Martínez Sánchez C; Pastelín Hernández G; Luna Ortiz P; Chávez Cosio E
    Arch Cardiol Mex; 2006; 76 Suppl 4():S76-101. PubMed ID: 17469337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed postconditioning in the mouse heart in vivo.
    Roubille F; Franck-Miclo A; Covinhes A; Lafont C; Cransac F; Combes S; Vincent A; Fontanaud P; Sportouch-Dukhan C; Redt-Clouet C; Nargeot J; Piot C; Barrère-Lemaire S
    Circulation; 2011 Sep; 124(12):1330-6. PubMed ID: 21875909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postconditioning: from the bench to bedside.
    Cour M; Gomez L; Mewton N; Ovize M; Argaud L
    J Cardiovasc Pharmacol Ther; 2011 Jun; 16(2):117-30. PubMed ID: 20938041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Endogenous cardioprotective mechanisms - what is it about and how does it work?].
    Beręsewicz A
    Kardiol Pol; 2011; 69 Suppl 3():59-66. PubMed ID: 22125205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological postconditioning protects isolated rat hearts against ischemia-reperfusion injury: the role of mitochondrial permeability transition pore.
    Duan X; Ji B; Yu K; Liu J; Hei F; Long C
    ASAIO J; 2011; 57(3):197-202. PubMed ID: 21317634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning.
    Heusch G
    Circ Res; 2015 Feb; 116(4):674-99. PubMed ID: 25677517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perconditioning and postconditioning: current knowledge, knowledge gaps, barriers to adoption, and future directions.
    Vinten-Johansen J; Shi W
    J Cardiovasc Pharmacol Ther; 2011; 16(3-4):260-6. PubMed ID: 21821526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial postconditioning: next step to cardioprotection.
    Rohilla A; Rohilla S; Kushnoor A
    Arch Pharm Res; 2011 Sep; 34(9):1409-15. PubMed ID: 21975801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs associated with ischemia-reperfusion injury and cardioprotection by ischemic pre- and postconditioning: protectomiRs.
    Varga ZV; Zvara A; Faragó N; Kocsis GF; Pipicz M; Gáspár R; Bencsik P; Görbe A; Csonka C; Puskás LG; Thum T; Csont T; Ferdinandy P
    Am J Physiol Heart Circ Physiol; 2014 Jul; 307(2):H216-27. PubMed ID: 24858849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mechanisms of myocardial cell protection from ischemia/reperfusion injury and potential clinical implications].
    Lamendola P; Di Monaco A; Barone L; Pisanello C; Lanza GA; Crea F
    G Ital Cardiol (Rome); 2009 Jan; 10(1):28-36. PubMed ID: 19292017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Realizing the clinical potential of ischemic preconditioning and postconditioning.
    Yellon DM; Hausenloy DJ
    Nat Clin Pract Cardiovasc Med; 2005 Nov; 2(11):568-75. PubMed ID: 16258568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unresolved issues in myocardial reperfusion injury.
    Buja LM; Weerasinghe P
    Cardiovasc Pathol; 2010; 19(1):29-35. PubMed ID: 19026571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efforts to reduce myocardial infarct size--the next step.
    Braunwald E
    J Cardiovasc Pharmacol Ther; 2011; 16(3-4):349-53. PubMed ID: 21821538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical Issues for the Translation of Cardioprotection.
    Heusch G
    Circ Res; 2017 Apr; 120(9):1477-1486. PubMed ID: 28450365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning.
    Hausenloy DJ; Tsang A; Yellon DM
    Trends Cardiovasc Med; 2005 Feb; 15(2):69-75. PubMed ID: 15885573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postconditioning--A new link in nature's armor against myocardial ischemia-reperfusion injury.
    Vinten-Johansen J; Zhao ZQ; Zatta AJ; Kin H; Halkos ME; Kerendi F
    Basic Res Cardiol; 2005 Jul; 100(4):295-310. PubMed ID: 15793629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondria "THE" target of myocardial conditioning.
    Boengler K; Lochnit G; Schulz R
    Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1215-H1231. PubMed ID: 30004243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology.
    Ovize M; Baxter GF; Di Lisa F; Ferdinandy P; Garcia-Dorado D; Hausenloy DJ; Heusch G; Vinten-Johansen J; Yellon DM; Schulz R;
    Cardiovasc Res; 2010 Aug; 87(3):406-23. PubMed ID: 20448097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.